Prognostic Value of Plasma Galectin-3 Concentrations for Cardiovascular Events in Patients with Heart Failure with Normal Left Ventricular Ejection Fraction

Prognostic Value of Plasma Galectin-3 Concentrations for Cardiovascular Events in Patients with Heart Failure with Normal Left Ventricular Ejection Fraction - Prognostic Value of Plasma Galectin-3 Concentrations for Cardiovascular Events in Patients with Heart Failure with Normal Left Ventricular Ejection Fraction

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014811

Enrollment

500

Registered

2014-08-10

Start date

2006-09-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure with normal left ventricular ejection fraction

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: a presence of HF symptoms 2 LVEF>50% 3 E/e'>15,or 8<E/e'<15 and BNP>200

Exclusion criteria

Exclusion criteria: Severe valvular heart disease Chronic renal failure requiring hemodialysis Active systemic inflammatory disease Severe collagen disease

Design outcomes

Primary

Measure	Time frame
CV death, non-fatal myocardial infarction or ischemic stroke, unstable angina pectoris, hospitalization for HF, or coronary revascularization	—

Countries

Japan

Contacts

Public ContactHiroaki Kusaka

Kumamoto University Graduate School of Medical Sciences Department of Cardiovascular Medicine

kusaka@kumamoto-u.ac.jp096-373-5175

Outcome results